Proportion of isolates with decreased susceptibility or resistance in Norway
Norway: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile
Proportion of isolates with decreased susceptibility or resistance in Norway, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
In 2018, proportion of isolates with decreased susceptibility or resistance in Norway stood at 0. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 100.0% on the previous year and down 100.0% over ten years.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Norway peaked at 6.52 in 2010 and was at its lowest, 0, in 2018.
That places Norway 15th out of 27 countries with data for 2018, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0.9091 | — |
| 2010 | 6.52 | +617.4% |
| 2011 | 1.3 | -80.1% |
| 2012 | 5.45 | +320.0% |
| 2013 | 4.46 | -18.2% |
| 2014 | 5.45 | +22.2% |
| 2015 | 0.9091 | -83.3% |
| 2016 | 1.8 | +98.2% |
| 2017 | 0.9 | -50.0% |
| 2018 | 0 | -100.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.9091 | 0.9091 | 0.9091 | 1 |
| 2010s | 2.98 | 0 | 6.52 | 9 |
Countries ranked near Norway
- 12 Germany 1 compare
- 13 Canada 0.5445 compare
- 14 United States of America 0.2907 compare
- 15 Estonia 0
- 15 Malta 0 compare
- 15 France 0 compare
- 15 Netherlands 0 compare
- 15 Slovakia 0 compare
- 15 Slovenia 0 compare
- 15 Iceland 0
- 15 Latvia 0 compare
- 15 Portugal 0 compare
- 15 Ireland 0 compare
- 15 Côte d'Ivoire 0
- 15 Denmark 0 compare
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Population ages 15-19, male, annual growth rate 1.48 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0313 units per person (2025)
- Population ages 20-24, female, annual growth rate 1.75 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0303 units per person (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Norway?
- Proportion of isolates with decreased susceptibility or resistance in Norway was 0 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Norway?
- The highest recorded value was 6.52 in 2010.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Norway?
- The lowest recorded value was 0 in 2018.
- How does Norway rank for proportion of isolates with decreased susceptibility or resistance?
- Norway ranks 15th out of 27 countries with data for 2018.
- Is proportion of isolates with decreased susceptibility or resistance rising or falling in Norway?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).